Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,405 | 227 | 92.5% |
| Education | $356.00 | 6 | 7.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Seagen Inc. | $452.52 | 13 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $398.78 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $362.33 | 16 | $0 (2024) |
| PFIZER INC. | $293.42 | 14 | $0 (2024) |
| Merck Sharp & Dohme LLC | $273.33 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $247.72 | 13 | $0 (2024) |
| Daiichi Sankyo Inc. | $218.86 | 14 | $0 (2024) |
| Incyte Corporation | $198.31 | 10 | $0 (2024) |
| Eisai Inc. | $190.34 | 10 | $0 (2024) |
| Genentech USA, Inc. | $177.93 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,195 | 59 | AstraZeneca Pharmaceuticals LP ($134.70) |
| 2023 | $1,612 | 80 | AstraZeneca Pharmaceuticals LP ($194.73) |
| 2022 | $1,520 | 68 | Seagen Inc. ($289.86) |
| 2021 | $433.55 | 26 | AbbVie Inc. ($58.99) |
All Payment Transactions
233 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Oncology | ||||||
| 11/15/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Oncology | ||||||
| 11/13/2024 | PFIZER INC. | ADCETRIS (Biological), PADCEV | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Oncology | ||||||
| 11/06/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Menarini Silicon Biosystems, Inc. | Cellsearch (Device) | Food and Beverage | Cash or cash equivalent | $15.21 | General |
| Category: Diagnostics | ||||||
| 09/05/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $19.99 | General |
| Category: Hematology | ||||||
| 08/20/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: Oncology | ||||||
| 08/08/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: Oncology | ||||||
| 08/05/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $30.61 | General |
| Category: Oncology | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.77 | General |
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.12 | General |
| 07/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.51 | General |
| 06/24/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.93 | General |
| Category: Oncology | ||||||
| 06/20/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $0.19 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.44 | General |
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 571 | 956 | $174,577 | $68,820 |
| 2022 | 5 | 494 | 816 | $155,361 | $62,103 |
| 2021 | 15 | 1,262 | 1,644 | $190,163 | $76,234 |
| 2020 | 23 | 2,364 | 3,279 | $343,555 | $135,104 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 330 | 705 | $129,720 | $52,656 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 85 | 95 | $15,105 | $5,900 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $15,080 | $5,410 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 58 | 58 | $14,152 | $4,518 | 31.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 40 | $520.00 | $336.00 | 64.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 290 | 608 | $111,872 | $45,861 | 41.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 68 | 68 | $17,680 | $6,527 | 36.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 31 | $7,967 | $3,407 | 42.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 40 | 40 | $9,760 | $3,328 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 38 | 39 | $6,201 | $2,517 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $1,677 | $412.30 | 24.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 17 | 17 | $204.00 | $50.40 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 299 | 382 | $66,374 | $27,116 | 40.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 329 | 450 | $51,012 | $18,535 | 36.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 132 | 132 | $27,192 | $14,276 | 52.5% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 29 | 36 | $13,104 | $6,541 | 49.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $10,298 | $3,696 | 35.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 12 | 12 | $3,708 | $1,651 | 44.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $3,324 | $963.35 | 29.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 236 | 290 | $3,480 | $870.00 | 25.0% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 23 | 23 | $2,561 | $684.28 | 26.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 14 | 24 | $2,472 | $582.12 | 23.5% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 41 | 50 | $2,200 | $513.24 | 23.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 12 | 12 | $1,632 | $377.08 | 23.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 34 | 45 | $2,070 | $329.14 | 15.9% |
About Sallie Walker, MS, RN, ARNP
Sallie Walker, MS, RN, ARNP is a Family healthcare provider based in Ardmore, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306889878.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sallie Walker, MS, RN, ARNP has received a total of $4,761 in payments from pharmaceutical and medical device companies, with $1,195 received in 2024. These payments were reported across 233 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($4,405).
As a Medicare-enrolled provider, Walker has provided services to 4,691 Medicare beneficiaries, totaling 6,695 services with total Medicare billing of $342,260. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Ardmore, OK
- Active Since 06/13/2006
- Last Updated 05/21/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1306889878
Products in Payments
- KEYTRUDA (Biological) $236.75
- ERLEADA (Drug) $194.89
- Lenvima (Drug) $190.34
- Enhertu (Drug) $169.20
- LIBTAYO (Biological) $135.94
- ENHERTU (Biological) $125.32
- JAKAFI (Drug) $113.10
- PADCEV (Biological) $102.90
- XTANDI (Drug) $100.03
- SARCLISA (Biological) $91.84
- INLYTA (Drug) $91.42
- ALUNBRIG (Drug) $89.37
- LYNPARZA (Drug) $88.45
- DOPTELET (Drug) $87.13
- KISQALI (Drug) $86.44
- MONJUVI (Drug) $85.21
- Zoladex (Drug) $79.90
- OPDIVO (Biological) $74.88
- IBRANCE (Drug) $69.00
- VERZENIO (Drug) $66.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Ardmore
Carrie Evans, Aprn-Cnp, APRN-CNP
Family — Payments: $5,535
Mrs. April Claxton, Aprn-Cnp, APRN-CNP
Family — Payments: $4,622
Mr. Justin Cheek, Aprn, Cnp, APRN, CNP
Family — Payments: $3,364
Mrs. Jamilia Broussard, Msn Rn Fnp-Bc Wcc, MSN RN FNP-BC WCC
Family — Payments: $2,750
Jennifer Sims, Np-C, NP-C
Family — Payments: $2,427
Anita Alaniz, Msn, Whnp, Fnp-C, MSN, WHNP, FNP-C
Family — Payments: $1,865